Medicaid Provider Alert: Provider revalidation has begun and those not completing the process risk disenrollment. Check your account now to learn when your revalidation is due. More information here.

Tailored Care Management for Williams & Colbert Class Members: Register to attend Aug. 4 virtual listening session

Drugs and Therapeutics (D & T) Committee Drugs Under Review for: September 14, 2011

Drug Name	Review Type	Class	Manufacturer
Incivek	New Drug Initial Review	Hepatitis C	Vertex
Victrelis	New Drug Initial Review	Hepatitis C	Merck
Natroba	New Drug Initial Review	Pediculicide	ParaPRO
Xarelto	New Drug Initial Review	Factor Xa Inhibitor	Johnson & Johnson
Tradjenta	New Drug Initial Review	DPP-4 Inhibitor	Boehringer-Ingelheim
Moxeza	New Drug Initial Review	Ophthalmic - Antibiotic	Alcon

Footer